We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$27.1M
AUM Growth
-$13.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$13.6M 50.21%
4,987,522
SPRB
2
Spruce Biosciences
SPRB
$182M
$8.6M 31.72%
39,150
OKUR
3
OnKure Therapeutics
OKUR
$155M
$4.05M 14.95%
253,422
XLO icon
4
Xilio Therapeutics
XLO
$59.3M
$793K 2.92%
102,960
VAPO
5
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$52.6K 0.19%
52,552

Similar funds

RiverVest Venture Management's Q4 2023 Portfolio in Review

As of Q4 2023, RiverVest Venture Management held 5 positions worth $27.1M, down 33% from $40.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's ten largest holdings make up 100% of its $27.1M portfolio in Q4 2023.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q4 2023.
  • RiverVest Venture Management's portfolio value fell 33% quarter-over-quarter to $27.1M.

Based on RiverVest Venture Management's 13F filing for Q4 2023, filed 12 Feb 2024.